Atrys Health S.A. | Mid-cap | Healthcare
€2.80
0.00%
| Atrys Health S.A Stock Comparison:
Atrys Health S.A vs Pharma Mar S.AAtrys Health S.A vs Oryzon Genomics S.AAtrys Health S.A vs Vytrus Biotech S.AAtrys Health S.A vs Biotechnology AssetsAtrys Health S.A vs Grifols, S.AAtrys Health S.A vs IBEX 35 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2016

Income Metrics

Balance Sheet Metrics

Total Assets 584.2M
Total Liabilities 331.0M
Shareholders Equity 253.2M
Debt to Equity 1.31

Cash Flow Metrics

Revenue & Profitability Trend

Atrys Health S.A Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i212.7M201.6M158.4M121.0M31.4M
Cost of Goods Sold i67.4M59.8M32.4M20.1M7.1M
Gross Profit i145.4M141.8M126.0M100.9M24.2M
Gross Margin % i68.3%70.3%79.6%83.4%77.2%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i-6.9M15.8M14.8M3.3M
Other Operating Expenses i28.7M31.1M12.0M10.2M7.0M
Total Operating Expenses i28.7M38.0M27.8M25.0M10.3M
Operating Income i9.2M1.3M-3.6M-12.4M-2.1M
Operating Margin % i4.3%0.7%-2.3%-10.2%-6.8%
Non-Operating Items
Interest Income i469.0K627.0K304.0K1.8M210.0K
Interest Expense i23.5M33.4M14.5M5.8M2.3M
Other Non-Operating Income-----
Pre-tax Income i-33.5M-33.7M-26.8M-24.9M-5.4M
Income Tax i-1.6M-2.9M-839.0K-1.7M167.0K
Effective Tax Rate % i0.0%0.0%0.0%0.0%0.0%
Net Income i-32.0M-45.9M-23.4M-23.2M-5.5M
Net Margin % i-15.0%-22.8%-14.8%-19.2%-17.7%
Key Metrics
EBITDA i36.0M29.1M21.4M3.2M3.1M
EPS (Basic) i€-0.42€-0.60€-0.34€-0.46€-0.20
EPS (Diluted) i€-0.42€-0.60€-0.34€-0.46€-0.20
Basic Shares Outstanding i7565238175983333682038105028294228315618
Diluted Shares Outstanding i7565238175983333682038105028294228315618

Income Statement Trend

Atrys Health S.A Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i20.4M41.8M34.3M35.1M17.5M
Short-term Investments i8.9M348.0K1.5M6.6M152.0K
Accounts Receivable i51.2M44.8M55.5M53.2M17.0M
Inventory i1.6M1.7M1.2M793.0K655.0K
Other Current Assets----0
Total Current Assets i89.2M100.9M101.9M101.8M37.3M
Non-Current Assets
Property, Plant & Equipment i58.2M9.9M10.6M62.5M3.1M
Goodwill i691.4M726.2M825.1M622.8M195.7M
Intangible Assets i156.7M174.7M212.7M151.1M52.8M
Long-term Investments-----
Other Non-Current Assets-1.0K---
Total Non-Current Assets i495.0M528.1M602.2M462.5M143.7M
Total Assets i584.2M629.0M704.0M564.3M181.0M
Liabilities
Current Liabilities
Accounts Payable i25.4M19.1M15.7M16.0M4.3M
Short-term Debt i14.3M71.6M48.3M18.4M12.8M
Current Portion of Long-term Debt-----
Other Current Liabilities6.2M-294.0K294.0K310.0K
Total Current Liabilities i99.8M103.6M100.6M71.5M21.4M
Non-Current Liabilities
Long-term Debt i151.8M189.7M210.5M136.6M59.6M
Deferred Tax Liabilities i32.5M35.5M44.9M30.7M7.4M
Other Non-Current Liabilities26.0M-6.7M5.8M5.7M
Total Non-Current Liabilities i231.2M235.5M267.1M220.2M88.2M
Total Liabilities i331.0M339.1M367.7M291.7M109.6M
Equity
Common Stock i760.0K760.0K760.0K614.0K347.0K
Retained Earnings i-31.8M-45.6M-23.1M-24.6M-5.5M
Treasury Stock i323.0K293.0K750.0K475.0K54.0K
Other Equity-----
Total Shareholders Equity i253.2M289.9M336.3M272.6M71.4M
Key Metrics
Total Debt i166.1M261.3M258.7M155.0M72.5M
Working Capital i-10.6M-2.8M1.3M30.3M15.9M

Balance Sheet Composition

Atrys Health S.A Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i-33.5M-33.7M-26.8M-24.9M-5.4M
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i0-1.7M-11.7M-5.9M-2.7M
Operating Cash Flow i652.0K2.4M-30.6M-12.5M-4.0M
Investing Activities
Capital Expenditures i-12.9M-13.1M-6.8M14.0M-3.2M
Acquisitions i-39.7M-61.8M-10.8M-46.7M
Investment Purchases i-200.0K-2.1M-3.6M-1.2M-71.0K
Investment Sales i143.0K----
Investing Cash Flow i-13.0M395.0K-58.2M1.9M-50.0M
Financing Activities
Share Repurchases i-27.0K----
Dividends Paid i-----
Debt Issuance i-14.5M49.9M11.8M45.1M
Debt Repayment i--2.7M-29.5M-92.7M-17.7M
Financing Cash Flow i-11.5M13.2M12.3M14.2M28.3M
Free Cash Flow i-10.1M-7.4M-30.6M-3.9M-6.7M
Net Change in Cash i-23.8M16.0M-76.5M3.6M-25.7M

Cash Flow Trend

Atrys Health S.A Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) -6.69
Forward P/E 35.13
Price to Book 0.85
Price to Sales 0.98
PEG Ratio 0.22

Profitability Ratios

Profit Margin -14.57%
Operating Margin 3.20%
Return on Equity -11.73%
Return on Assets 0.20%

Financial Health

Current Ratio 0.89
Debt to Equity 100.85
Beta 0.67

Per Share Data

EPS (TTM) €-0.42
Book Value per Share €3.33
Revenue per Share €2.87

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
atry214.1M-6.690.85-11.73%-14.57%100.85
Pharma Mar S.A 1.4B33.616.8321.94%22.20%25.51
Oryzon Genomics S.A 203.9M-44.561.96-4.20%-58.55%15.22
Vytrus Biotech S.A 41.4M39.295.6816.23%16.76%24.31
Biotechnology Assets 24.1M10.773.56-44.40%-98.39%31.56
Grifols, S.A 7.8B29.191.694.99%4.00%126.87

Financial data is updated regularly. All figures are in the company's reporting currency.